Skip to content

Validation of an Allergic Rhinitis Control Test in Teenagers

Validation of an Allergic Rhinitis Control Test in Teenagers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02818153
Acronym
ARCTado
Enrollment
200
Registered
2016-06-29
Start date
2016-06-30
Completion date
2017-06-30
Last updated
2016-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Keywords

Allergic rhinitis

Brief summary

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in adolescents or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitsis (ARCT) in patients from 12 years of age. However, this study included only 67 adolescents aged 12 to 17 years old and lacked power. In this new study,the investigators propose, following exactly the same procedure as the pilot study of 2008, to confirme the validation of unmodified Adult questionnaire in adolescents 12 to 17 years inclusive.

Interventions

OTHERSelf questionnaire for allergic rhinitis control

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 12 to 17 years old, consulting a practitioner for an allergic rhinitis * parents formulated their study participation agreement by signing the consent form.

Exclusion criteria

* Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatement.

Design outcomes

Primary

MeasureTime frame
Score of the allergic rhinitis control self questionnaire in teenagers from 12 to 17 years old.15 days

Countries

France

Contacts

Primary ContactPascal Demoly, Professor
pascal.demoly@inserm.fr+334 67 33 61 27
Backup ContactAnca Chiriac, MD
a-chiriac@chu-montpellier.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026